To increase the reliability of final diagnosis of non-PCa, we excluded patients with the diagnosis of non-PCa based on follow-up less than 48 months, which majorly led to the significant difference in PSA and PI-RADS scores between patients included and excluded. This evidence concerns the gene KLK3 and posterior cortical atrophy.